Sommeil et cancer du sein : existe-t-il un lien ?

Malina, C; Frigo, S; Mathelin, Carole

doi:10.1016/j.gyobfe.2012.12.008

Cited by 5 publications

(1 citation statement)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The pineal gland then converts serotonin to the antioxidant hormone melatonin [57], which does not raise BC markers such as circulating estradiol and IGF-1 [58]. Quality sleep promoted by adequate melatonin secretion actually lowers risk of BC [59] and enhances the patient's chances of survival [60].…”

Section: Tryptophan-rich Dietmentioning

confidence: 99%

Reversing Breast Cancer in a Premenopausal Woman: A Case for Phyto-Nutritional Therapy

Yap¹

2015

Int. J. Biotech. Well. Indus.

View full text Add to dashboard Cite

Globally, breast cancer incidence increases at 1% to 2% annually. It is the number one cause of cancer death in women. Current literature implies that soy food intake is linked to decreased risk of breast cancer due to its rich isoflavones. On the other hand, intake of animal fat, red meat, organ meat and high-fat dairy products during premenopausal years may increase risk for this cancer, but no apparent risk has been established for fish or poultry intake. Monounsaturated fat and the improved ratio of omega-3 to omega-6 fatty acids have showed potential to reduce risk. On the other hand, high glycemic index diet but not glycemic load is associated with a significantly increased risk. Central rather than general obesity carries similar risk. Furthermore, lifestyle rather than genetic differences are widely implicated in breast cancer. A comprehensive phyto-nutritional therapy was adopted for treating a case involving stage IV breast cancer in a premenopausal woman, who was turned away by a hospital offering conventional treatment. The therapy involved designing and monitoring the implementation of dietary plans to achieve optimum health outcomes for the major abnormal metabolic blood/urine markers identified for this particular patient. Nutrient-dense food items with generous servings of a variety of spices and herbs, supplemented by vitamins, minerals and phyto-extracts was prescribed as part of the therapy. Many non-toxic dietary nutrients and phytonutrients are known cytotoxic agents promoting cancer regression via apoptosis pathways, which have yet to be fully understood. Conclusion: The complete remission of the malignancy initiated by this natural therapy would suggest that an advanced stage breast cancer is a metabolic disorder reversible by an evidence-based phyto-nutritional therapy. While not all cases of malignancy can possibly be completely reversed, the positive outcome achieved in partnership with the patient warrants further study involving larger number of women with similar level of malignancy.

show abstract

Section: Tryptophan-rich Dietmentioning

confidence: 99%

Reversing Breast Cancer in a Premenopausal Woman: A Case for Phyto-Nutritional Therapy

Yap¹

2015

Int. J. Biotech. Well. Indus.

View full text Add to dashboard Cite

show abstract

Breast cancer epidemic in the early twenty-first century: evaluation of risk factors, cumulative questionnaires and recommendations for preventive measures

et al. 2016

View full text Add to dashboard Cite

Rapidly increasing incidence of breast cancer is a new social challenge resulting from a spectrum of internal and external risk factors which appear to be well accepted as an attribute of the early twenty-first century, being, however, new for female sub-populations compared to the past. These include altered socio-economical conditions such as occupational exposure, rotating shift work, specific environmental factors (increased pollution and environmental toxicity, altered dietary habits, quality and composition of meal) as well as consequently shifted and/or adapted physiologic factors such as lower age at menarche, late age of first full-term pregnancy, if any, shorter periods of breastfeeding and later menopause. Consolidated expert statements suggest that over 50 % of all breast cancer cases may be potentially prevented by risk reduction strategy such as regulation of modifiable risk factors. Currently available risk assessment models may estimate potential breast cancer predisposition, in general; however, they are not able to predict the disease manifestation individually. Further, current deficits in risk assessment and effective breast cancer prevention have been recently investigated and summarised as follows: gaps in risk estimation, preventive therapy, lifestyle prevention, understanding of the biology of breast cancer risk and implementation of known preventive measures. This paper overviews the most relevant risk factors, provides recommendations for improved risk assessment and proposes an extended questionnaire for effective preventive measures.

show abstract